1100022I SRI international; to X9 obra--1 optimization phase in vitro admet and small animal PK studies; biod can 8470038; $737,296

Ended Awarded Last action

Contract number
HHSN27200009
Awardee
Awarding agency
Obligated
$1,913,866

Award facts

Opportunity
  • NIHAI2010090 Solicitation number
Contract value 86% obligated
  • $1,913,866.00 Current, with exercised options
  • $2,229,476.00 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 4 offers Basic Research
Pricing
Firm Fixed Price
Place of performance
Menlo Park, CA 94025, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Exercise an Option 4 · To exercise options 1C and 1D with the period of performance 9/13/2017-10/05/2018 $315,610
Exercise an Option 3 · To exercise options 2A, 2B, 2C, and 2D with the period of performance 4/16/2017-09/30/2018 $329,572
Funding Only Action 2 · To correct administrative error and modify article f.1. Period of performance to read 12/16/16-10/05/18 for options 1A, 1B, 3A-3F. $531,388
Exercise an Option 1 · To exercise options 1A, 1B, 3A-3F. 1100022I SRI international; to X9 obra--1 optimization phase in vitro admet and small animal PK studies; biod can 8470038;… $0
Original award $737,296

About this award

This is a federal contract award to SRI International, a non-profit research and development institute, by the National Institute of Allergy and Infectious Diseases (NIAID), a division of the U.S. Department of Health and Human Services. The award, valued at $2,229,476.00, is for a delivery order to conduct preclinical services, including in vitro ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) studies and small animal pharmacokinetic studies, in support of the development of interventional agents for infectious diseases. This award is not associated with a set-aside program and is part of a larger NIAID program for preclinical services. SRI International has extensive experience conducting biomedical research and providing technical services to federal agencies through both contracts and grants.

Quick answers

Who was awarded contract HHSN27200009?

HHSN27200009 was awarded to Sri International by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on February 17, 2016.

How much is contract HHSN27200009 worth?

The government has obligated $1,913,866 on HHSN27200009. Its potential value, with all options, is $2,229,476.

Is contract HHSN27200009 an order under another contract?

Yes. HHSN27200009 is a delivery order under HHSN272201100022I, an indefinite delivery contract.

Was contract HHSN27200009 competed?

The extent of competition for HHSN27200009 was full and open competition. The government received 4 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award